Cite
MLA Citation
Patrick F. Smith et al.. “A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers.” British journal of clinical pharmacology, vol. 83, 2017, pp. 2367–2376. http://access.bl.uk/ark:/81055/vdc_100053333993.0x00004a